venBio Partners’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

venBio Partners’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,158,162	Closed	-$321M	–	6
2023 Q4	$321M	Hold	5,158,162	–	–	48.06%	1
2023 Q3	$115M	Buy	+5,158,162	New	+$108M	32.47%	1

venBio Partners's RYZB Position: Q1 2024 in Review

venBio Partners sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 5,158,162 shares — an estimated $321M sold.

venBio Partners first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $321M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

venBio Partners reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
venBio Partners sold 5,158,162 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $321M.
venBio Partners first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
venBio Partners's RayzeBio, Inc. Common Stock position peaked at $321M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on venBio Partners's 13F filing for Q1 2024, filed 15 May 2024.